Shukra Pharmaceuticals Limited (NSE:SHUKRAPHAR)
India · Delayed Price · Currency is INR 56.05
-2.54 (-4.34%)
Last updated: Sep 23, 2026, 3:29 PM IST
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 25.03 billion as of September 23, 2026. Its market cap has increased by 79.34% in one year.
Market Cap
25.03B
Enterprise Value
25.02B
Revenue
748.59M
Ranking
n/a
PE Ratio
73.64
Stock Price
56.05
ChartMarket Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 25.03B, an increase of 54,117.09%. That is a compound annual growth rate of 53.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 25.03B | -3.53% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 43.81B |
| Unichem Laboratories | 40.34B |
| Kwality Pharmaceuticals | 38.65B |
| Hikal | 28.70B |
| Shukra Pharmaceuticals | 25.03B |
| Fredun Pharmaceuticals | 23.08B |
| Venus Remedies | 22.00B |
| Syncom Formulations (India) | 18.83B |